ARTW 10-Q Quarterly Report Feb. 29, 2012

ARTS WAY MANUFACTURING CO INC

10-Ks and 10-Qs

10-Q	Quarter ended Aug. 31, 2025
10-Q	Quarter ended May 31, 2025
10-Q	Quarter ended Feb. 28, 2025
10-K	Fiscal year ended Nov. 30, 2024
10-Q	Quarter ended Aug. 31, 2024
10-Q	Quarter ended May 31, 2024
10-Q	Quarter ended Feb. 29, 2024
10-K	Fiscal year ended Nov. 30, 2023
10-Q	Quarter ended Aug. 31, 2023
10-Q	Quarter ended May 31, 2023
10-Q	Quarter ended Feb. 28, 2023
10-K	Fiscal year ended Nov. 30, 2022
10-Q	Quarter ended Aug. 31, 2022
10-Q	Quarter ended May 31, 2022
10-Q	Quarter ended Feb. 28, 2022
10-K	Fiscal year ended Nov. 30, 2021
10-Q	Quarter ended Aug. 31, 2021
10-Q	Quarter ended May 31, 2021
10-Q	Quarter ended Feb. 28, 2021
10-K	Fiscal year ended Nov. 30, 2020
10-Q	Quarter ended Aug. 31, 2020
10-Q	Quarter ended May 31, 2020
10-Q	Quarter ended Feb. 29, 2020
10-K	Fiscal year ended Nov. 30, 2019
10-Q	Quarter ended Aug. 31, 2019
10-Q	Quarter ended May 31, 2019
10-Q	Quarter ended Feb. 28, 2019
10-K	Fiscal year ended Nov. 30, 2018
10-Q	Quarter ended Aug. 31, 2018
10-Q	Quarter ended May 31, 2018
10-Q	Quarter ended Feb. 28, 2018
10-K	Fiscal year ended Nov. 30, 2017
10-Q	Quarter ended Aug. 31, 2017
10-Q	Quarter ended May 31, 2017
10-Q	Quarter ended Feb. 28, 2017
10-K	Fiscal year ended Nov. 30, 2016
10-Q	Quarter ended Aug. 31, 2016
10-Q	Quarter ended May 31, 2016
10-Q	Quarter ended Feb. 29, 2016
10-K	Fiscal year ended Nov. 30, 2015
10-Q	Quarter ended Aug. 31, 2015
10-Q	Quarter ended May 31, 2015
10-Q	Quarter ended Feb. 28, 2015
10-K	Fiscal year ended Nov. 30, 2014
10-Q	Quarter ended Aug. 31, 2014
10-Q	Quarter ended May 31, 2014
10-Q	Quarter ended Feb. 28, 2014
10-K	Fiscal year ended Nov. 30, 2013
10-Q	Quarter ended Aug. 31, 2013
10-Q	Quarter ended May 31, 2013
10-Q	Quarter ended Feb. 28, 2013
10-K	Fiscal year ended Nov. 30, 2012
10-Q	Quarter ended Aug. 31, 2012
10-Q	Quarter ended May 31, 2012
10-Q	Quarter ended Feb. 29, 2012
10-K	Fiscal year ended Nov. 30, 2011
10-Q	Quarter ended Aug. 31, 2011
10-Q	Quarter ended May 31, 2011
10-Q	Quarter ended Feb. 28, 2011
10-K	Fiscal year ended Nov. 30, 2010
10-Q	Quarter ended Aug. 31, 2010
10-Q	Quarter ended May 31, 2010
10-Q	Quarter ended Feb. 28, 2010
10-K	Fiscal year ended Nov. 30, 2009

PROXIES

DEF 14A	Filed on April 23, 2025
DEF 14A	Filed on March 14, 2025
DEF 14A	Filed on April 23, 2024
DEF 14A	Filed on March 15, 2024
DEF 14A	Filed on April 26, 2023
DEF 14A	Filed on March 15, 2023
DEF 14A	Filed on April 20, 2022
DEF 14A	Filed on March 14, 2022
DEF 14A	Filed on March 17, 2021
DEF 14A	Filed on March 17, 2020
DEF 14A	Filed on March 15, 2019
DEF 14A	Filed on March 26, 2018
DEF 14A	Filed on March 28, 2017
DEF 14A	Filed on March 28, 2016
DEF 14A	Filed on March 25, 2015
DEF 14A	Filed on March 25, 2014
DEF 14A	Filed on March 25, 2013
DEF 14A	Filed on March 26, 2012
DEF 14A	Filed on March 25, 2011
DEF 14A	Filed on March 26, 2010

10-Q 1 artsway_10q-022912.htm FORM 10Q artsway_10q-022912.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[x]	Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended February 29, 2012

[ ]	Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ______ to ______

Commission File No. 0-5131

ART’S-WAY MANUFACTURING CO., INC.

(Exact name of registrant as specified in its charter)

	DELAWARE	42-0920725
	(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

5556 Highway 9

Armstrong, Iowa 50514

(Address of principal executive offices)

(712) 864-3131

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.:

Large Accelerated filer o Accelerated filer o

Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

Number of common shares outstanding as of March 30, 2012: 4,029,852

RDGPreambleEnd

Art’s-Way Manufacturing Co., Inc.

Index

		Page No.

PART I – FINANCIAL INFORMATION		1
Item 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets
	February 29, 2012 and November 30, 2011	1
	Condensed Consolidated Statements of Operations
	Three-month period ended February 29, 2012 and February 28, 2011	2
	Condensed Consolidated Statements of Cash Flows
	Three-month period ended February 29, 2012 and February 28, 2011	3
	Notes to Condensed Consolidated Financial Statements	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 4.	Controls and Procedures	15
PART II – OTHER INFORMATION		16
Item 1.	Legal Proceedings	16
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3.	Defaults Upon Senior Securities	16
Item 4.	Mine Safety Disclosures	16
Item 5.	Other Information	16
Item 6.	Exhibits	17
	SIGNATURES	18
	Exhibit Index	19

PART I – FINANCIAL INFORMATION

RDGXBRLParseBegin

Item 1. Financial Statements

ART’S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Balance Sheets


	(Unaudited)
Assets	February 29, 2012		November 30, 2011
Current assets:
Cash	$	316,488	$	118,924
Accounts receivable-customers, net of allowance for doubtful accounts of $17,508 and $49,583 in 2012 and 2011, respectively		3,099,127		2,030,369
Inventories, net		14,379,561		13,249,105
Deferred taxes		888,055		933,497
Cost and Profit in Excess of Billings		10,001		164,730
Income taxes receivable		28,097		-
Other current assets		381,081		198,930
Total current assets		19,102,410		16,695,555
Property, plant, and equipment, net		8,029,579		8,085,719
Assets held for lease, net		424,575		452,441
Assets held for sale, net		185,308		186,362
Covenant not to Compete, net		45,000		60,000
Goodwill		375,000		375,000
Total assets	$	28,161,872	$	25,855,077
Liabilities and Stockholders’ Equity
Current liabilities:
Notes payable to bank	$	1,142,000	$	1,388,965
Current portion of term debt		722,276		712,962
Accounts payable		1,456,824		341,738
Customer deposits		2,165,840		338,484
Billings in Excess of Cost and Profit		266,733		74,052
Accrued expenses		1,098,957		1,363,276
Income taxes payable		-		350,996
Total current liabilities		6,852,630		4,570,473
Long-term liabilities
Deferred taxes		803,965		810,904
Term debt, excluding current portion		5,570,546		5,743,159
Total liabilities		13,227,141		11,124,536
Stockholders’ equity:
Common stock – $0.01 par value. Authorized 5,000,000 shares; issued and outstanding 4,028,852 and 4,025,852 shares in 2012 and 2011		40,289		40,259
Additional paid-in capital		2,471,895		2,461,233
Retained earnings		12,422,547		12,229,049
Total stockholders’ equity		14,934,731		14,730,541
Total liabilities and stockholders’ equity	$	28,161,872	$	25,855,077

See accompanying notes to condensed consolidated financial statements.

ART’S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended
	February 29, 2012			February 28, 2011
Net sales	$	6,312,216		$	4,664,338
Cost of goods sold		4,835,995			4,188,503
Gross profit		1,476,221			475,835
Expenses:
Engineering		85,060			118,309
Selling		366,783			400,608
General and administrative		662,125			615,874
Total expenses		1,113,968			1,134,791
Income (loss) from operations		362,253			(658,956	)
Other income (expense):
Interest expense		(93,040	)		(96,202	)
Other		19,865			26,069
Total other income (loss)		(73,175	)		(70,133	)
Income (loss) before income taxes		289,078			(729,089	)
Current tax expense (benefit)		57,076			(314,512	)
Deferred tax expense		38,504			70,000
Net income (loss)	$	193,498		$	(484,577	)

Net income per share:
Basic net income (loss) per share	$	0.05		$	(0.12	)
Diluted net income (loss) per share	$	0.05		$	(0.12	)
Weighted average outstanding shares used to compute basic net income per share		4,028,193			4,010,068
Weighted average outstanding shares used to compute diluted net income per share		4,046,125			4,010,068

See accompanying notes to condensed consolidated financial statements.

ART’S-WAY MANUFACTURING CO., INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Year To Date
	February 29, 2012			February 28, 2011
Cash flows from operations:
Net income (loss)	$	193,498		$	(484,577	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation		10,692			-
Depreciation expense		190,661			181,420
Amortization expense		15,000			15,000
Deferred income taxes		38,504			70,000
Changes in assets and liabilities:
(Increase) decrease in:
Accounts receivable		(1,068,758	)		807,660
Inventories		(1,130,456	)		(372,131	)
Income taxes receivable		(28,097	)		(360,645	)
Other current assets		(182,151	)		(156,488	)
Increase (decrease) in:
Accounts payable		1,115,086			(414,043	)
Contracts in progress, net		347,410			221,670
Customer deposits		1,827,356			3,312,061
Income taxes payable		(350,997	)		(594,816	)
Accrued expenses		(264,319	)		(208,800	)
Net cash provided by operating activities		713,429			2,016,311
Cash flows from investing activities:
Purchases of property, plant, and equipment		(105,601	)		(284,869	)
Net cash (used in) investing activities		(105,601	)		(284,869	)
Cash flows from financing activities:
Proceeds from line of credit borrowings		2,945,000			1,523,000
Repayment of line of credit borrowings		(3,191,965	)		(3,292,000	)
Payments of notes payable to bank		(163,299	)		(148,158	)
Proceeds from the exercise of stock options		-			38,951
Net cash (used in) provided by financing activities		(410,264	)		(1,878,207	)
Net increase (decrease) in cash		197,564			(146,765	)
Cash at beginning of period		118,924			317,103
Cash at end of period	$	316,488		$	170,338

Supplemental disclosures of cash flow information:
Cash paid/(received) during the period for:
Interest	$	94,317		$	98,007
Income taxes		436,900			640,850

See accompanying notes to condensed consolidated financial statements.

Notes to Unaudited Condensed Consolidated Financial Statements

(1) Description of the Company

Unless otherwise specified, as used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Art’s-Way,” and the “Company,” refer to Art’s-Way Manufacturing Co., Inc., a Delaware corporation headquartered in Armstrong, Iowa, and its wholly-owned subsidiaries.

We began operations as a farm equipment manufacturer in 1956. Since that time, we have become a major worldwide manufacturer of agricultural equipment. Our principal manufacturing plant is located in Armstrong, Iowa.

We have organized our business into three operating segments. Management separately evaluates the financial results of each segment because each is a strategic business unit offering different products and requiring different technology and marketing strategies. Art’s-Way Manufacturing Co., Inc. manufactures farm equipment under its own and private labels. Art’s-Way Manufacturing Co., Inc. has two wholly-owned operating subsidiaries. Art’s-Way Vessels, Inc. (“Art’s-Way Vessels”) manufactures pressure vessels and Art’s-Way Scientific, Inc. (“Art’s-Way Scientific”) manufactures modular buildings for various uses, commonly animal containment and research laboratories. For detailed financial information relating to segment reporting, see Note 12, “Segment Information.”

(2) Summary of Significant Account Policies

Statement Presentation

The foregoing condensed consolidated financial statements of the Company are unaudited and reflect all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the interim periods. The financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2011. The results of operations for the three months ended February 29, 2012 are not necessarily indicative of the results for the fiscal year ending November 30, 2012.

Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the three months ended February 29, 2012. Actual results could differ from those estimates.

(3) Net Income (Loss) Per Share of Common Stock

Basic net income per common share has been computed on the basis of the weighted average number of common shares outstanding. Diluted net income per share has been computed on the basis of the weighted average number of common shares outstanding plus equivalent shares assuming exercise of stock options.

Basic and diluted earnings per common share have been computed based on the following as of February 29, 2012 and February 28, 2011:

	For the three months ended
	February 29, 2012		February 28, 2011
Basic:
Numerator, net income	$	193,498	$	(484,577	)
Denominator: Average number of common shares outstanding		4,028,193		4,010,068
Basic earnings per common share	$	0.05	$	(0.12	)
Diluted:
Numerator, net income	$	193,498	$	(484,577	)
Denominator: Average number of common shares outstanding		4,028,193		4,010,068
Effect of dilutive stock options		17,932		0
		4,046,125		4,010,068
Diluted earnings per common share	$	0.05	$	(0.12	)

(4) Inventory

Major classes of inventory are:

	February 29, 2012			November 30, 2011
Raw materials	$	8,689,238		$	7,623,095
Work in process		555,402			394,158
Finished goods		7,881,430			7,982,192
	$	17,126,070		$	15,999,445
Less: Reserves		(2,746,509	)		(2,750,340
	$	14,379,561		$	13,249,105

(5) Accrued Expenses

Major components of accrued expenses are:

	February 29, 2012		November 30, 2011
Salaries, wages, and commissions	$	388,606	$	672,407
Accrued warranty expense		184,137		201,630
Other		526,214		489,239
	$	1,098,957	$	1,363,276

(6) Product Warranty

The Company offers warranties of various lengths to its customers depending on the specific product and terms of the customer purchase agreement. The average length of the warranty period is one year from the date of purchase. The Company’s warranties require it to repair or replace defective products during the warranty period at no cost to the customer. The Company records a liability for estimated costs that may be incurred under its warranties. The costs are estimated based on historical experience and any specific warranty issues that have been identified. Although historical warranty costs have been within expectations, there can be no assurance that future warranty costs will not exceed historical amounts. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the balance as necessary. The accrued warranty balance is included in accrued expenses as shown in note 5.

Changes in the Company’s product warranty liability for the three months ended February 29, 2012 and February 28, 2011 are as follows:

	For the three months ended
	February 29, 2012			February 28, 2011
Balance, beginning	$	201,630		$	180,549
Settlements made in cash or in-kind		(143,059	)		(133,510	)
Warranties issued		125,566			99,862
Balance, ending	$	184,137		$	146,901

(7) Loan and Credit Agreements

The Company has a $6,000,000 revolving line of credit with West Bank (the “Line of Credit”) which is scheduled to mature on April 30, 2012. The Line of Credit is renewable annually with advances funding the Company’s working capital and letter of credit needs. We expect to renew the Line of Credit prior to the April 30, 2012 maturity date. The interest rate is West Bank’s prime interest rate, adjusted daily, with a minimum rate of 4.00%. As of February 29, 2012, the interest rate was the minimum of 4.0%. Monthly interest-only payments are required and the unpaid principal is due on the maturity date. As of February 29, 2012 and November 30, 2011, the Company had borrowed $1,142,000 and $1,389,000, respectively, against the Line of Credit. The available amounts remaining on the Line of Credit were $4,858,000 and $4,611,000 on February 29, 2012 and November 30, 2011, respectively. The borrowing base limits advances from the Line of Credit to 60% of accounts receivable less than 90 days, 60% of finished goods inventory, 50% of raw material inventory and work-in-process inventory, plus 40% of Net Book Value of Fixed Assets as calculated at each month-end. The Company’s obligations under the Line of Credit are evidenced by a Business Loan Agreement effective March 31, 2011 (the “Business Loan Agreement”), a change in Terms Agreement effective March 31, 2011 and certain other ancillary documents.

On June 7, 2007, the Company obtained a term loan from West Bank in the amount of $4,100,000. The loan, which had an outstanding principal balance of $2,718,000 as of February 29, 2012, matures on May 1, 2013 and bears fixed interest at 5.75%. Monthly principal and interest payments in the amount of $42,500 are required, with a final payment of principal and accrued interest in the amount of $2,302,000 due on May 1, 2013.

The Company obtained two additional loans from West Bank in 2007 for the purpose of financing the construction of the Company’s new facilities in Monona and Dubuque. On October 9, 2007, the Company obtained a loan for $1,330,000, which has a maturity date of May 1, 2013 and bears interest at a fixed interest rate of 5.75%. Monthly payments of $11,000 are required for principal and interest, with a final payment of accrued interest and principal in the amount of $1,006,000 due on May 1, 2013. On February 29, 2012, the outstanding principal balance on this loan was $1,085,000.

On November 30, 2007, the Company obtained a $1,500,000 construction loan to finance construction of the Dubuque, Iowa facility, which has a maturity date of May 1, 2013 and bears interest at a fixed interest rate of 5.75%. Payments of $12,550 are due monthly for principal and interest, with a final accrued interest and principal payment in the amount of $1,145,000 due on May 1, 2013. On February 29, 2012, the outstanding principal balance on this loan was $1,234,000.

Each of the Company’s loans from West Bank is governed by the Business Loan Agreement, which requires the Company to comply with certain financial and reporting covenants. The Company must provide monthly internally prepared financial reports, year-end audited financial statements, annual compliance certificates, and notice upon certain events, such as a change in executive or management personnel. The Company must maintain a minimum debt service coverage ratio of 1.5, a maximum debt to tangible net worth ratio of 1.25, and a minimum tangible net worth of $12,000,000, each as measured at the Company’s fiscal year-end. Further, the Company must obtain West Bank’s prior written consent for any investment in, acquisition of, or guaranty relating to another business or entity. The loans are secured by a first position security interest on the assets of the Company and its subsidiaries, including but not limited to, inventories, accounts receivable, machinery, equipment and real estate, in accordance with the Business Loan Agreement and Commercial Guaranties executed by the Company’s subsidiaries. The Company and its subsidiaries were also required to execute Agreements to Provide Insurance that set forth the insurance requirements for the collateral.

If the Company or either of its subsidiaries (as guarantors) commits an event of default under the Business Loan Agreement and fails or is unable to cure that default, the interest rate on the Line of Credit would increase by 2.0%. In addition, West Bank may cease advances under the Line of Credit and has the option of causing all outstanding indebtedness to become immediately due and payable. Events of default include, without limitation: (i) becoming insolvent or subject to bankruptcy proceedings; (ii) defaulting on any obligations to West Bank; (iii) defaulting on any obligations to third parties that would materially affect the ability to perform obligations owed to West Bank; (iv) suffering a material adverse change in financial condition or the value of any collateral; (v) experiencing a change in ownership of twenty-five percent or more of outstanding common stock; and (vi) making false statements to West Bank.

The Company was in compliance with all covenants under the Business Loan Agreement as measured on November 30, 2011. As of February 29, 2012, the Company’s debt service coverage ratio was below the minimum required by the Business Loan Agreement. The Company remains in compliance with the terms of the Business Loan Agreement, and was not required to obtain a waiver with respect to its debt service coverage ratio, because compliance with the financial covenants contained in the Business Loan Agreement are measured on an annual basis. The next measurement date is November 30, 2012.

On June 1, 2009, Art’s-Way Scientific received funds from two $95,000 promissory notes in connection with an agreement signed August 7, 2007 between Art’s-Way Scientific and the Iowa Department of Economic Development. The first $95,000 promissory note was a 0% interest loan requiring 60 monthly payments of $1,583, and an original maturity date of July 1, 2014. The second $95,000 promissory note was a forgivable loan subject to certain contract obligations. The obligations included maintaining Art’s-Way Scientific’s principal place of business in Iowa, complying with certain tax and insurance requirements, and creating 16 full-time positions and retaining 21 full-time positions in Iowa, which must be maintained for a two-year period. During the fiscal year ended November 30, 2011, the Iowa Department of Economic Development was required to audit the job attainment of Art’s Way Scientific. Art’s Way Scientific had obtained approximately 48% of the job retention and creation requirements and was required, during the fourth quarter of the fiscal year ending November 30, 2011, to restructure the original two promissory notes into three separate notes. The first note is now a 6% interest-bearing note requiring a monthly payment of $2,437 that had a balance of $61,000 as of February 29, 2012 and has a maturity date of June 1, 2014. The second note is an interest-free note requiring a monthly payment of $813 which had a balance of $22,000 as of February 29, 2012, with a final payment due June 1, 2014. The third note is a forgivable loan subject to contract obligations which will be measured during April 2012. The forgivable loan had a balance of $49,000 as of February 29, 2012. Art’s-Way Manufacturing Co., Inc. has provided a guarantee in connection with these loans to Art’s-Way Scientific.

On May 1, 2010, the Company obtained a loan to finance the purchase of an additional facility located in West Union, Iowa to be used as a distribution center, warehouse facility, and manufacturing plant for certain products under the Art’s-Way brand. The funds for this loan were made available by the Iowa Finance Authority by the issuance of tax exempt bonds. This loan had an original principal amount of $1,300,000 and bears fixed interest at 3.5%. The payments required on this loan began July 1, 2010 and will continue until June 1, 2020. The terms of the loan require monthly payments of $12,892 for principal and interest. As of February 29, 2012, the outstanding principal balance on this loan was $1,115,000.

This loan from the Iowa Finance Authority, which has been assigned to The First National Bank of West Union, is governed by a Manufacturing Facility Revenue Note dated May 28, 2010 and a Loan Agreement dated May 1, 2010 (“the IFA Loan Agreement”), which requires the Company to provide quarterly internally prepared financial reports and year-end audited financial statements and to maintain a minimum debt service coverage ratio of 1.5 to 1.0, which is measured at November 30 of each year. Among other covenants, the IFA Loan Agreement also requires the Company to maintain proper insurance on, and maintain in good repair, the West Union Facility, and continue to conduct business and remain duly qualified to do business in the State of Iowa. The loan is secured by a mortgage on the Company’s West Union Facility, pursuant to a Mortgage, Security Agreement, Assignment of Leases and Rents and Fixture Financing Statement dated May 1, 2010 between the Company and The First National Bank of West Union (the “West Union Mortgage”).

If the Company fails to make a required payment or perform any other covenant under the IFA Loan Agreement or the West Union Mortgage, becomes subject to bankruptcy or insolvency proceedings, defaults in payment on any of our other loan obligations in excess of $100,000, or if there is a determination that any of the Company’s representations made in the IFA Loan Agreement or related documents are materially false, the Company will be deemed to have committed an event of default under the IFA Loan Agreement. If the Company does not cure the event of default within the time specified by the IFA Loan Agreement, the lender may cause the entire amount of the loan to be immediately due and payable and take any other action that it is permitted to take at law or in equity to enforce the Company’s performance.

On September 15, 2010, the company obtained a zero-interest loan from the West Union Community Development Corporation in the amount of $13,000. Annual principal payments of $4,333.33 are due September 1 of 2011, 2012, and 2013. On February 29, 2012, the outstanding principal balance on this loan was $9,000.

A summary of the Company’s term debt is as follows:

	February 29, 2012		November 30, 2011
West Bank loan payable in monthly installments of $42,500 including interest at 5.75%, due May 1, 2013	$	2,717,696	$	2,804,403

West Bank loan payable in monthly installments of $11,000 including interest at 5.75%, due May 1, 2013		1,085,438		1,102,321
West Bank loan payable in monthly installments of $12,550 including interest at 5.75%, due May 1, 2013		1,234,184		1,253,508
Iowa Finance Authority loan payable in monthly installments of $12,892 including interest at 3.5%, due June 1, 2020		1,114,604		1,143,140
IDED loan payable in monthly installments of $2,437 including interest at 6%, due June 1, 2014		61,430		70,024
IDED loan payable in monthly installments of $813 including interest at 0%, due June 1, 2014		21,973		25,228

IDED loan payable in monthly installments of $0 including interest at 0%, due July 1, 2014		48,830		48,830

West Union Community Development Corporation loan payable in annual installments of $4,333 including interest at 0% due September 1, 2013		8,667		8,667

Total term debt	$	6,292,822	$	6,456,121
Less current portion of term debt		722,276		712,962
Term debt, excluding current portion	$	5,570,546	$	5,743,159

(8) Recently Issued Accounting Pronouncements

Goodwill Impairment Testing

In December 2010, the FASB issued standards on testing goodwill and other intangible assets impairment which is a two-step test. When a goodwill impairment test is performed (either on an annual or interim basis), an entity must assess whether the carrying amount of a reporting unit exceeds its fair value (Step 1). If it does, an entity must perform an additional test to determine whether goodwill has been impaired and to calculate the amount of that impairment (Step 2). The objective of this Update is to address questions about entities with reporting units with zero or negative carrying amounts because some entities concluded that Step 1 of the test is passed in those circumstances because the fair value of their reporting unit will generally be greater than zero. The amendment will affect all entities that have recognized goodwill and have one or more reporting units whose carrying amount for purposes of performing Step 1 of the goodwill impairment test is zero or negative. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2010, with no early adoption permitted. The Company has determined that there was no significant impact to the financial statements as a result of the adoption of these standards.

In September 2011, the FASB issued standards to address concerns about the cost and complexity of performing the first step of the two-step goodwill impairment test required under Topic 350, Intangibles-Goodwill and Other. The objective of this Update is to simplify how entities, both public and nonpublic, test goodwill for impairment. The amendments in the Update permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. Under the amendments in this Update, an entity is not required to calculate the fair value of a reporting unit unless the entity determines that it is more likely than not that its fair value is less than its carrying amount. The Company has determined that there was no significant impact to the financial statements as a result of the adoption of these standards.

Disclosure of Supplementary Pro Forma Information for Business Combinations

In December 2010, the FASB issued standards which state that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period. The amendments in this Update clarify the acquisition date that should be used for reporting the pro forma financial information disclosures when comparative financial statements are presented. The amendments also improve the usefulness of the pro forma revenue and earnings disclosures by requiring a description of the nature and amount of material, nonrecurring pro forma adjustments that are directly attributable to the business combination(s). The amendments in this Update are effective prospectively for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. The Company has determined that there was no significant impact to the financial statements as a result of the adoption of these standards

Fair Value Measurement Update

In May 2011, the FASB issued ASU No. 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” that amends the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and disclosing information about fair value measurements. The amendments in this update achieve the objective of developing common fair value measurement and disclosure requirements, as well as improving consistency and understandability. Some of the requirements clarify the FASB’s intent about the application of existing fair value measurement requirements while other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The amendments in this ASU are effective prospectively for interim and annual periods beginning after December 15, 2011, with no early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.

Comprehensive Income

In June 2011, the FASB issued ASU NO. 2011-05, “Presentation of Comprehensive Income” that improves the comparability, consistency, and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statements of changes in stockholders’ equity. The amendments in this standard require that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. The standard does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, the standard does not affect the calculation or reporting of earnings per share. For public entities, the amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and are to be applied retrospectively, with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.

In December 2011, the FASB issued ASU (Accounting Standards Update) No. 2011-12 which stated that the new presentation requirements about reclassifications of items out of accumulated other comprehensive income would be difficult for preparers and may add unnecessary complexity to financial statements. In addition it is difficult for some stakeholders to change systems in time to gather the information for the new presentation requirements by the effective date of Update 2011-05. Given these issues, they asked the Board to reconsider whether it is necessary to require entities to present reclassification adjustments by component in both the statement where net income is presented and the statement where other comprehensive income is presented for both interim and annual financial statements. Because those pending paragraphs are effective on a retrospective basis for public entities for annual periods beginning after December 15, 2011, and interim periods within those years, those stakeholders asked the Board, at a minimum, to defer the effective date pertaining to reclassification adjustments out of accumulated other comprehensive income in Accounting Standards Update 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income, until the Board is able to reconsider those paragraphs.

In order to defer only those changes in Update 2011-05 that relate to the presentation of reclassification adjustments, the paragraphs in this Update supersede certain pending paragraphs in Update 2011-05. The amendments are being made to allow the Board time to confirm whether to present on the face of the financial statements the effects of reclassifications out of accumulated other comprehensive income on the components of net income and other comprehensive income for all periods presented. While the Board is considering the operational concerns about the presentation requirements for reclassification adjustments and the needs of financial statement users for additional information about reclassification adjustments, entities should continue to report reclassifications out of accumulated other comprehensive income consistent with the presentation requirements in effect before Update 2011-05. All other requirements in Update 2011-05 are not affected by this Update, including the requirement to report comprehensive income either in a single continuous financial statement or in two separate but consecutive financial statements. Public entities must apply these requirements for fiscal years, and interim periods within those years, beginning after December 15, 2011. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.

(9) Equity Incentive Plan and Stock Based Compensation

On January 27, 2011, the Board of Directors of the Company authorized and approved the Art’s-Way Manufacturing Co., Inc. 2011 Equity Incentive Plan (the “2011 Plan”). The 2011 Plan was approved by the stockholders on April 28, 2011. It replaced the Employee Stock Option Plan and the Directors’ Stock Option Plan (collectively, the “Prior Plans”), and no further stock options will be awarded under the Prior Plans. Awards to directors and executive officers under the 2011 Plan will be governed by the forms of agreement approved by the Board of Directors.

The 2011 Plan permits the plan administrator to award nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance awards, and stock appreciation rights to employees (including officers), directors, and consultants. The Board of Directors has approved a director compensation policy pursuant to which non-employee directors are automatically granted non-qualified stock options to purchase 2,000 shares of common stock annually or initially upon their election to the Board, which are fully vested.

Stock options granted prior to January 27, 2011 are governed by the applicable Prior Plan and the forms of agreement adopted thereunder.

Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant vesting period. We estimate the fair value of each stock-based award on the measurement date using the Black-Scholes option valuation model which incorporates assumptions as to stock price volatility, the expected life of the options, risk-free interest rate, and dividend yield. Expected volatility is based on historical volatility of the Company’s stock and other factors. The Company uses historical option exercise and termination data to estimate the expected term the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected dividend yield is calculated using historical dividend amounts and the stock price at the option issuance date.

(10) Disclosures About the Fair Value of Financial Instruments

The fair value of a financial instrument is defined as the amount at which the instrument could be exchanged in a current transaction between willing parties. At February 29, 2012, and November 30, 2011, the carrying amount approximated fair value for cash, accounts receivable, accounts payable, notes payable to bank, and other current and long-term liabilities. The carrying amounts approximate fair value because of the short maturity of these instruments. The fair value of the Company’s installment term loans payable also approximate recorded value because the interest rates charged under the loan terms are not substantially different than current interest rates.

(11) Related Party Transactions

The financial statements of Art’s-Way Manufacturing Inc. include a purchase by our Manufacturing division from Bauer Corporation for $1,100 during the quarter ending February 29, 2012. The terms of this purchase were consistent with those of an arm’s length transaction. Bauer Corporation is wholly-owned and operated by J. Ward McConnell Jr., the Chairman of the Board of Directors.

The financial statements of Art’s-Way Manufacturing, Inc. include a sale by our Vessels division to Adamson Global Technology for $17,000 during quarter ending February 28, 2011. The terms of this sale were consistent with those of an arm’s length transaction. Adamson Global Technology is wholly-owned and operated by J. Ward McConnell, Jr., the Chairman of the Board of Directors.

(12) Segment Information

There are three reportable segments: agricultural products, pressurized vessels and modular buildings. The agricultural products segment fabricates and sells farming products as well as replacement parts for these products in the United States and worldwide. The pressurized vessel segment produces pressurized tanks. The modular building segment produces modular buildings for animal containment and various laboratory uses.

The accounting policies applied to determine the segment information are the same as those described in the summary of significant accounting policies. Management evaluates the performance of each segment based on profit or loss from operations before income taxes, exclusive of nonrecurring gains and losses.

Approximate financial information with respect to the reportable segments is as follows.

Three Months Ended February 29, 2012

	Agricultural Products		Pressurized Vessels			Modular Buildings		Consolidated
Revenue from external customers	$	3,988,000	$	330,000		$	1,994,000	$	6,312,000
Income (loss) from operations		136,000		(88,000	)		314,000		362,000
Income (loss) before tax		137,000		(144,000	)		296,000		289,000
Total Assets		20,633,000		2,773,000			4,756,000		28,162,000
Capital expenditures		77,000		14,000			15,000		106,000
Depreciation & Amortization		124,000		29,000			53,000		206,000

Three Months Ended February 28, 2011

	Agricultural Products			Pressurized Vessels			Modular Buildings			Consolidated
Revenue from external customers	$	3,656,000		$	563,000		$	445,000		$	4,664,000
Income (loss) from operations		(250,000	)		(204,000	)		(205,000	)		(659,000	)
Income (loss) before tax		(244,000	)		(260,000	)		(225,000	)		(729,000	)
Total Assets		20,391,000			3,204,000			2,913,000			26,508,000
Capital expenditures		65,000			18,000			202,000			285,000
Depreciation & Amortization		141,000			26,000			29,000			196,000

(13) Subsequent Event

Management evaluated all activity of the Company and concluded that no subsequent events have occurred that would require recognition in the condensed consolidated financial statements or disclosure in the notes to the condensed consolidated financial statements.

RDGXBRLParseEnd

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and notes thereto included in Item 1 of Part I of this report and the audited consolidated financial statements and related notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended November 30, 2011. Some of the statements in this report may contain forward-looking statements that reflect our current view on future events, future business, industry and other conditions, our future performance, and our plans and expectations for future operations and actions. In some cases you can identify forward-looking statements by the use of words such as “may,” “should,” “anticipate,” “believe,” “expect,” “plan,” “future,” “intend,” “could,” “estimate,” “predict,” “hope,” “potential,” “continue,” or the negative of these terms or other similar expressions. Many of these forward-looking statements are located in this report under “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” but they may appear in other sections as well. Forward-looking statements in this report generally relate to: (i) the anticipated benefits of our efforts to improve our disclosure controls and procedures and remediate the material weakness in our internal control over financial reporting; (ii) our order backlog; (iii) our beliefs regarding the sufficiency of working capital and our continued ability to renew or obtain financing on reasonable terms when necessary; and (iv) the anticipated benefits of separating the positions of Chief Executive Officer and Chief Financial Officer.

You should read this report thoroughly with the understanding that our actual results may differ materially from those set forth in the forward-looking statements for many reasons, including events beyond our control and assumptions that prove to be inaccurate or unfounded. We cannot provide any assurance with respect to our future performance or results. Our actual results or actions could and likely will differ materially from those anticipated in the forward-looking statements for many reasons, including but not limited to: (i) delays in or obstacles to our ability to successfully improve our disclosure controls and procedures and remediate the material weakness in our internal control over financial reporting; (ii) the impact of tightening credit markets on our ability to continue to obtain financing on reasonable terms; (iii) our ability to continue to meet debt obligations; (iv) the effect of general economic conditions on the demand for our products and the cost of our supplies and materials; (v) unforeseen costs or delays in implementing production of new products; (vi) unexpected effects from changes to our production schedule; (vii) an inability to retain new customers for our modular buildings; and (viii) other factors described from time to time in our reports to the SEC. We do not intend to update the forward-looking statements contained in this report other than as required by law. We caution you not to put undue reliance on any forward-looking statements, which speak only as of the date of this report. You should read this report and the documents that we reference in this report and have filed as exhibits completely and with the understanding that our actual future results may be materially different from what we currently expect. We qualify all of our forward-looking statements by these cautionary statements.

Critical Accounting Policies

Our critical accounting policies involving the more significant judgments and assumptions used in the preparation of the financial statements as of February 29, 2012 have remained unchanged from November 30, 2011. These policies include revenue recognition, inventory valuation, income taxes and stock-based compensation. Disclosure of these critical accounting policies is incorporated by reference from Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended November 30, 2011.

Results of Operations

Net Sales and Cost of Sales

Our consolidated corporate sales for the three-month period ended February 29, 2012 were $6,312,000, compared to $4,664,000 during the same period in 2011, an increase of $1,648,000, or 35.3%. The agricultural products segment (“Manufacturing”) had a sales increase of $332,000 and the modular buildings segment (“Scientific”) had a sales increase of $1,549,000. The pressurized vessels segment (“Vessels”) had a decrease of $233,000.

Consolidated gross profit margin for the first fiscal quarter of 2012 was 23.4% compared to 10.2% during the first fiscal quarter of 2011. The increase in gross margin for the quarter was due to Manufacturing, Vessels, and Scientific gross margin improving from 16.3% to 26.3%, (18.8%) to (12.6%) and (2.9%) to 23.5%, respectively. The impact of increases brought the consolidated gross margin up by approximately 13.2%.

Our first fiscal quarter sales at Manufacturing were $3,988,000, compared to $3,656,000 during the same period of 2011, an increase of $332,000, or 9.2%. Gross margin for the quarter ended February 29, 2012 was 26.3% compared to 16.3% for the same period in 2011. The increase in margin during the first fiscal quarter 2012 versus 2011 was due to the change in product mix sold for this time period.

Our first fiscal quarter sales at Vessels were $330,000, compared to $563,000 for the same period in 2011, a decrease of $233,000, or 41.4%. We have experienced a reduction in sales due to economic conditions. Our production levels were not sufficient to absorb our fixed overhead costs; consequently our Vessels segment continued to experience negative gross margins. Gross margin for the quarter ended February 29, 2012 was (12.6%), compared to (18.8%) for the same period in 2011.

Our first fiscal quarter sales in 2012 at Scientific were $1,994,000, compared to $445,000 for the same period in fiscal 2011, an increase of $1,549,000, or 348.4%. The increase was primarily attributable to revenue from a $7 million contract executed in January 2012. Scientific was hired to manufacture twenty-four modular units over the course of approximately one year. Gross margin for the quarter ended February 29, 2012 was 23.5% compared to (2.9%) for the same period in 2011. The gross margin increase was primarily due to the $7 million contract.

Expenses

Our first fiscal quarter consolidated selling expenses were $367,000 compared to $401,000 for the same period in 2011. The decrease was primarily due to reductions in trade show, advertising, and literature expenditures. Selling expenses as a percentage of sales were 5.8% for the three-month period ended February 29, 2012, compared to 8.6% for the same period in 2011.

Consolidated engineering expenses were $85,000 for the three months ended February 29, 2012, compared to $118,000 for the same period in 2011. Engineering expenses as a percentage of sales were 1.3% for the three-month period ended February 29, 2012, compared to 2.5% for the same period in 2011. We are actively working on filling two open positions in our Engineering department.

Consolidated administrative expenses for the three months ended February 29, 2012 were $662,000 compared to $616,000 for the same period in 2011. Administrative expenses as a percentage of sales were 10.5% for the three-month period ended February 29, 2012, compared to 13.2% for the same period in 2011.

Net Income

Net Income was $193,000 for the first fiscal quarter of 2012, compared to a net loss of $485,000 for the first fiscal quarter of 2011. The changes to net income were primarily attributable to an increase in consolidated sales for the three-month period ended February 29, 2012.

Order Backlog

The consolidated order backlog as of March 29, 2012 was $18,478,000 compared to $13,578,000 as of March 29, 2011. Manufacturing’s order backlog was $11,921,000 as of March 29, 2012, compared to $12,337,000 in fiscal 2011. The backlog for Vessels was $373,000 as of March 29, 2012, compared to $331,000 in fiscal 2011. The backlog for Scientific was $6,184,000 as of March 29, 2012, compared to $910,000 in fiscal 2011. Our order backlog is not necessarily indicative of future revenue to be generated from such orders due to the possibility of order cancellations and dealer discount arrangements we may enter into from time to time.

Liquidity and Capital Resources

Our primary source of funds in the first quarter was customer deposits for Manufacturing. Those funds were primarily used to pay down our line of credit and finance working capital needs. We have a $6,000,000 revolving Line of Credit with West Bank, pursuant to which we had borrowed $1,142,000 and $1,389,000 as of February 29, 2012 and November 30, 2011, respectively. The Line of Credit is renewable annually and is scheduled to mature on April 30, 2012. We expect to renew the Line of Credit prior to the April 30, 2012 maturity date. In addition, we have three term loans from West Bank, which had outstanding principal balances of approximately $2,718,000, $1,085,000 and $1,234,000 as of February 29, 2012, respectively. We have also received funds pursuant to three promissory notes from the Iowa Department of Economic Development. These notes had outstanding principal balances of approximately $61,000, $22,000, and $49,000 as of February 29, 2012, respectively. In May 2010, the Iowa Finance Authority extended us a loan to finance the purchase of a facility. As of February 29, 2012, the outstanding principal balance on this loan was approximately $1,115,000. In September 2010, we obtained an interest-free $13,000 loan from the West Union Community Development Corporation, which requires annual principal payments of $4,333 on September 1 of 2011, 2012, and 2013. On February 29, 2012, the outstanding principal balance on this loan was $9,000.

Our loans require us to comply with various covenants, including maintaining certain financial ratios. We were in compliance with all financial ratio covenants as of November 30, 2011, our last measurement date.

For additional information about our financing activities, please refer to note 8 to the audited consolidated financial statements and the discussion entitled “Liquidity and Capital Resources,” each contained in our Annual Report on Form 10-K for the fiscal year ended November 30, 2011, as well as note 7 to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report.

We believe that our current financing arrangements provide sufficient cash to finance operations for the next 12 months. We expect to continue to rely on cash from financing activities to supplement our cash flows from operations in order to meet our liquidity and capital expenditure needs in the near future. We expect to continue to be able to procure financing upon reasonable terms.

Off Balance Sheet Arrangements

None.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

The persons serving as our principal executive officer and principal financial officer have evaluated the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) or Rule 15d-15(e), as of the end of the period subject to this Report. Based on this evaluation, the persons serving as our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective and provide reasonable assurance that information required to be disclosed by us in the periodic and current reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the periods specified by the Securities and Exchange Commission’s rules and forms.

Changes to Internal Control over Financial Reporting

During the fiscal year ending November 30, 2011, we focused on key issues that contributed to the material weakness on inventory accounting that was reported in the fiscal 2010 Annual Report on Form 10-K. We provided additional inventory management training to the staff and enhanced our procedures for testing and verifying inventory counts and valuation. We believe that the procedural changes, additional analysis, and our enforcement of these procedures enhanced the effectiveness of these controls. We will continue to review these procedures for effectiveness and change them as deemed necessary.

Effective January 26, 2012, Jason Feucht was promoted to Chief Financial Officer. In connection with Mr. Feucht’s appointment, Carrie Majeski, the President and Chief Executive Officer, will no longer server as the Principal Financial Officer. By separating the roles of Chief Executive Officer and Chief Financial Officer, we believe that we will enhance the effectiveness and the supervision of our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

We are currently not a party to any material pending legal proceedings.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not applicable .

Item 5. Other Information.

None.

Item 6. Exhibits.

See “Exhibit Index” on page 18 of this report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ART’S-WAY MANUFACTURING CO., INC.


Date: April 13, 2012	By:	/s/ Carrie L. Majeski
		Carrie L. Majeski
		President and Chief Executive Officer

Date: April 13, 2012	By:	/s/ Jason D. Feucht
		Jason D. Feucht
		Chief Financial Officer

Art’s-Way Manufacturing Co., Inc.

Exhibit Index

Form 10-Q for the Quarterly Period Ending February 29, 2012

Exhibit No.		Description
10.1		Employment Agreement, by and between the Company and Carrie L. Majeski, dated December 20, 2011 - incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated December 20, 2011.
10.2		Amendment to Employment Agreement, by and between the Company and Carrie L. Majeski, dated January 26, 2012 – filed herewith
31.1		Certificate of Chief Executive Officer pursuant to 17 CFR 13a-14(a) – filed herewith
31.2		Certificate of Chief Financial Officer pursuant to 17 CFR 13a-14(a) – filed herewith
32.1		Certificate of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 – filed herewith
32.2		Certificate of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 – filed herewith
101*		The following materials from this report, formatted in XBRL (Extensible Business Reporting Language) are filed herewith: (i) condensed consolidated balance sheets, (ii) condensed consolidated statement of operations, (iii) condensed consolidated statements of cash flows, and (iv) the notes to the condensed consolidated financial statements.


*		Pursuant to Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be deemed part of a registration statement, prospectus or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filings.

TABLE OF CONTENTS

Part I Financial Information Item 1. Financial Statements Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 4. Controls and Procedures Part II Other Information Item 1. Legal Proceedings Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 3. Defaults Upon Senior Securities Item 4. Mine Safety Disclosures Item 5. Other Information Item 6. Exhibits

ARTW 10-Q Quarter ended Feb. 29, 2012